Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06715020Recruiting
Testing a new imaging method for breast cancer treatment
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
BeijingAges 18–75 - NCT06710418Recruiting
Comparing two red blood cell transfusion thresholds for people with high-grade myeloid neoplasms, AML or B-ALL
This study compares two different strategies for when to give red blood cell transfusions to people receiving intensive chemotherapy or stem cell transplant for high-grade myeloid neoplasms, AML or B-ALL. The goal is to see which approach better improves quality of life and daily function.
Seattle, WashingtonAges 18 years+ - NCT06713811Recruiting
Electronic monitoring to help you take your blood meds
This trial is testing if a special electronic device can help you remember to take your oral medications for blood disorders. It's for people who need to take pills for at least 6 months and who have internet access.
AmiensAges 18 years+ - NCT06705803Recruiting
Prostate cancer ablation registry study
This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.
Hyde Park, IllinoisAges 22 years+ - NCT06715293Recruiting
Wireless sensor capsule for detecting upper GI bleeding
This trial tests a wireless optical sensor capsule that you swallow to find the source of bleeding in your upper stomach or food pipe. It may help doctors diagnose upper gastrointestinal bleeding without a standard endoscopy tube.
Shatin, Hong Kong IslandAges 18 years+ - NCT06709495RecruitingPhase 1/Phase 2
PEEL-224 with chemo for teens and young adults with sarcoma
This trial tests a new drug called PEEL-224 combined with two chemotherapy drugs (vincristine and temozolomide) for people ages 12 to 49 with sarcoma that has come back or hasn't responded to standard treatments. The goal is to see if this combination is safe and effective.
Boston, MassachusettsAges 12–49 - NCT06708000Enrolling by invitationPhase 3
Personalized testing for new chest pain
This trial compares a personalized evaluation approach to standard care for people with new chest pain who might have heart disease. It aims to see if tailoring tests can improve diagnosis and outcomes.
HerningAges 30–75 - NCT06705751Recruiting
Faster diagnosis of abnormal coronary artery origin
This study tests a new, faster way to diagnose an uncommon heart condition where one of the main arteries (the coronary artery) starts from the wrong place on the aorta. The goal is to help doctors find and treat it sooner.
San Donato Milanese, ItaliaAges 6 years+ - NCT06705829Recruiting
Comparing blood clotting tests for clotting factor deficiencies
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
StrasbourgAges 18 years+ - NCT06007547RecruitingPhase 4
Preventive surfactant therapy for preterm babies
This trial tests whether giving surfactant (a foam that helps lungs stay open) before breathing problems start can help very premature babies (born before 30 weeks) breathe better. It might reduce the need for a breathing tube.
Evanston, IllinoisAges Up to 15 minutes - NCT06473610Recruiting
Residual blood clots seen on lung scan study
This trial uses a special lung scan (SPECT-CT) to look for leftover blood clots in people with high blood pressure in the lungs or ongoing shortness of breath after a clot. It may help doctors better understand these conditions.
Saint-EtienneAges 18 years+ - NCT06649890Recruiting
Testing a new irrigation solution in breast reconstruction after mastectomy
This study tests a new surgical irrigation solution (Xperience) used during breast reconstruction after double mastectomy. It aims to see if it can reduce complications and improve outcomes for people receiving implants or tissue expanders.
Chapel Hill, North CarolinaAges 18 years+ - NCT06689566Recruiting
Genistein for heart attack recovery and inflammation
This study tests whether genistein, a natural compound found in soy, can help reduce inflammation and improve heart health in people who have had a heart attack and are overweight or have other risk factors.
Taipei, TaiwanAges 18 years+ - NCT05613985Recruiting
Ultrasound light added to usual care for infected diabetic foot ulcers
This trial tests whether adding the VULNOFAST Plus/VULNOLIGHT system to usual care can heal infected diabetic foot ulcers more safely and effectively. It compares the added treatment plus usual care versus usual care alone.
ArezzoAges 18 years+ - NCT05319132Recruiting
Test a lab treatment for ROSAH syndrome using blood cells
This trial studies DF-003 in lab tests using blood immune cells taken from people with ROSAH syndrome. It aims to see whether the treatment works in lab “ex vivo” tests and could guide future options.
Lyon, Auvergne-Rhône-AlpesAges 18 years+ - NCT05866835Recruiting
Digital mouth guard safety and fit check in boxing or rugby
This study tests a digitalised way of providing or checking an intraoral (mouth) protection device for people who play contact sports like boxing, rugby, or football. It mainly checks whether the protection can be safely used for eligible participants.
BordeauxAges 16–35 - NCT06375564RecruitingPhase 1
A new radioactive drug for advanced solid tumors
This trial tests a new radioactive drug (177Lu-AB-3PRGD2) that targets a protein called integrin αvβ3 found on many solid tumors. It is for people whose cancer has not responded to or has come back after several standard treatments.
Xiamen, FujianAges 18–90 - NCT06697314Recruiting
Clot removal for acute pulmonary embolism with heart strain
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
PoznanAges 18 years+ - NCT06704672Recruiting
Effect of a new glucose sensor on blood sugar control in diabetes
This study compares a continuous glucose monitor (CGM) to fingerstick testing for people with type 1 or type 2 diabetes who give themselves insulin injections. It aims to see if using the sensor helps increase the time blood sugar stays in a healthy range.
GdanskAges 18 years+ - NCT06701513Recruiting
Real-world study of deucravacitinib for plaque psoriasis
This study looks at how well deucravacitinib works for adults with moderate to severe plaque psoriasis in everyday medical practice. It helps doctors understand the real-world benefits of this treatment.
AmiensAges 18 years+ - NCT06703892RecruitingPhase 1
CAR T-cell therapy for relapsed B-cell lymphoma
This trial tests a new type of CAR T-cell therapy that targets two proteins (CD20 and CD19) on your cancer cells. It is for people with certain types of lymphoma that have not responded to or have come back after at least two prior treatments.
TaipeiAges 18–70 - NCT06698887Recruiting
Long-term safety study of idecabtagene vicleucel for multiple myeloma in Korea
This study follows up on Korean adults with multiple myeloma who received the CAR T-cell therapy idecabtagene vicleucel (also called Ide-cel) in a previous trial (KarMMa-9) and did not have an optimal response after a stem cell transplant. The goal is to monitor long-term safety.
Hwasun, JeonranamdoAges 18 years+ - NCT06693960RecruitingEarly Phase 1
Oregano and drug interaction study
This study looks at how oregano affects the way your body processes certain medications. It might help patients understand if oregano can change how drugs work.
Spokane, WashingtonAges 18–64 - NCT06697418Enrolling by invitation
Physical activity and heart health in peritoneal dialysis patients
This study uses a wrist-worn device to see how daily physical activity affects heart health and other outcomes for people on peritoneal dialysis. If you are on PD, can walk on your own, and are willing to wear a tracker, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–75
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.